Align Technology, Inc. (ALGN) — Fair Value Analysis

Base-case fair value (P50): $229.57 · Current price: $181.31 · Verdict: Undervalued

The Verdict on ALGN

Based on our proprietary Monte Carlo simulations, Align Technology (ALGN) is not overvalued. In fact, our analysis suggests ALGN is Deeply Undervalued. With the current share price at $181.31, our median fair value (P50) points to $229.57, indicating a substantial +26.6% upside potential. This robust valuation suggests the market is currently underpricing ALGN relative to its intrinsic value, as derived from thousands of forward-looking financial scenarios.

How ALGN stacks up against Healthcare

Align Technology operates within the Healthcare sector, where its operational and financial health is categorized as "strong." This strong quality tier reflects the company's robust fundamentals and competitive positioning relative to sector peers. The consistent performance underpinning this "strong" rating contributes significantly to the calculated fair value of $229.57, making the current price of $181.31 particularly attractive, especially for a company exhibiting such strong financial health in its sector.

What this means for investors

For investors considering ALGN, the verdict of "Deeply Undervalued" coupled with a "strong" quality tier presents a compelling narrative. The Monte Carlo simulations project a significant +26.6% potential from the current $181.31 to the median fair value of $229.57. While this analysis provides a clear outlook, investors seeking a deeper understanding of ALGN's valuation drivers, including the full probabilistic distribution and specific bear and bull case scenarios, can gain further insights through FairCurve. Sign up for FairCurve to see the full bear/bull distribution and track ALGN's fair value as new fundamentals are released.